Effect of YM435, a Dopamine DA 1 Receptor Agonist, in a Canine Model of Ischemic Acute Renal Failure - an update of dopamine and a first look at dobutamine

By Yatsu T.   Arai Y.   Takizawa K.   Kasai-Nakagawa C.   Takanashi M.   Uchida W.   Inagaki O.   Tanaka A.   Takenaka T.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 803-807

Elsevier

Access to resources Recommend Favorite

Dopamine DA 1 Receptor Agonist Activity of YM435 in the Canine Renal Vasculature

By Yatsu T.   Uchida W.   Inagaki O.   Tanaka A.   Takenaka T.  

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 229-232

Elsevier

Access to resources Recommend Favorite

Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats

By Yatsu T.   Aoki M.   Inagaki O.  

European Journal of Pharmacology, Vol. 461, Iss. 2, 2003-02 ,pp. : 191-195

Elsevier

Access to resources Recommend Favorite

Effects of YM 435 and A 77636 on Dopamine D-1 Receptors in Bovine Retina In Vitro

By Ofori S.   De Raad S.   Bugnon O.   Schorderet M.  

General Pharmacology, Vol. 26, Iss. 1, 1995-01 ,pp. : 51-57

Elsevier

Access to resources Recommend Favorite

DOI, a 5-HT 2 receptor agonist, induces renal vasodilation via nitric oxide in anesthetized dogs

By Tian R.-X.   Kimura S.   Kondou N.   Fujisawa Y.   Zhou M.-S.   Yoneyama H.   Kosaka H.   Rahman M.   Nishiyama A.   Abe Y.  

European Journal of Pharmacology, Vol. 437, Iss. 1, 2002-02 ,pp. : 79-84

Elsevier

Access to resources Recommend Favorite